You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

131-I

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Neuroblastoma, Childhood Metastatic Pheochromocytoma Trial in Philadelphia (131 I-Metaiodobenzylguanidine (131 I-MIBG), 131

Available
  • Neuroblastoma
  • Childhood Metastatic Pheochromocytoma
  • 131 I-Metaiodobenzylguanidine (131 I-MIBG)
  • 131 I-MIBG
  • Philadelphia, Pennsylvania
    The Children's Hospital of Philadelphia
Jul 11, 2022

Locally Advanced Solid Tumors, Metastatic Solid Tumors Trial in Edmonton ([131]I-IAZA)

Withdrawn
  • Locally Advanced Solid Tumors
  • Metastatic Solid Tumors
  • Edmonton, Alberta, Canada
    Cross Cancer Institute
Jul 7, 2022

HER2-positive Breast Cancer Trial in Shanghai (68Ga/131I-SGMIB-5F7)

Not yet recruiting
  • HER2-positive Breast Cancer
  • 68Ga/131I-SGMIB-5F7
  • Shanghai, China
    Huashan Hospital
Aug 1, 2023

Kidney Cancer Trial in New York (Iodine-131 radiolabeled chimeric mAb G250 (131I-cG250))

Completed
Has Results
  • Kidney Cancer
  • Iodine-131 radiolabeled chimeric monoclonal antibody G250 (131I-cG250)
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Oct 3, 2022

Thyroid Cancer Trial in Bialystok (metformin, Radioactive iodine (I-131))

Not yet recruiting
  • Thyroid Cancer
  • Bialystok, Poland
    Department of Endocrinology, Diabetology and Internal Medicine,
Jul 26, 2022

Renal Tracer Elimination in Thyroid Cancer Patients Treated With

Completed
  • Thyroid Carcinoma
    • Jena, Thüringen, Germany
      University Hospital Jena
    Dec 15, 2022

    Relapsed Neuroblastoma, Metastatic Pheochromocytoma Trial in Dallas (131 I-Metaiodobenzylguanidine, Potassium Iodide, G-csf)

    No longer available
    • Relapsed Neuroblastoma
    • Metastatic Pheochromocytoma
    • 131 I-Metaiodobenzylguanidine
    • +2 more
    • Dallas, Texas
      The University of Texas Southwestern Medical Center
    Apr 13, 2022

    Neoplastic Disease, Glioblastoma, Glioblastoma Multiforme Trial (131I-IPA)

    Not yet recruiting
    • Neoplastic Disease
    • +2 more
    • (no location specified)
    Jul 6, 2022

    Melanoma Trial in Clermont-Ferrand ([131I]ICF01012 (therapeutic dose level 1), [131I]ICF01012 (therapeutic dose level 2),

    Recruiting
    • Melanoma
    • [131I]ICF01012 (therapeutic dose level 1)
    • +3 more
    • Clermont-Ferrand, France
    • +1 more
    Jan 27, 2022

    CNS/Leptomeningeal Tumors Trial in New York (131I-omburtamab)

    Available
    • Central Nervous System/Leptomeningeal Neoplasms
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Jul 15, 2022

    Thyroid Cancer Trial in New York (131 I-iodine (131-I), 124 I-iodine (124-I))

    Active, not recruiting
    • Thyroid Cancer
    • 131 I-iodine (131-I), 124 I-iodine (124-I)
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Apr 1, 2022

    Neuroblastoma Trial in Canada, United States (131I-MIBG, Vincristine, Irinotecan)

    Completed
    Has Results
    • Neuroblastoma
    • 131I-MIBG
    • +3 more
    • Los Angeles, California
    • +13 more
    May 16, 2022

    Neuroblastoma, Pheochromocytoma Trial in New Hyde Park (131-I-meta-iodobenzylguanidine)

    Available
    • Neuroblastoma
    • Pheochromocytoma
    • New Hyde Park, New York
      Cohen Children's Medical Center
    Apr 4, 2022

    Relapsed Neuroblastoma, Metastatic Pheochromocytoma Trial in Minneapolis (131 I-Metaiodobenzylguanidine (131I-MIBG), Potassium

    Recruiting
    • Relapsed Neuroblastoma
    • Metastatic Pheochromocytoma
    • 131 I-Metaiodobenzylguanidine (131I-MIBG)
    • +3 more
    • Minneapolis, Minnesota
      University of Minnesota Masonic Cancer Center
    Jan 20, 2022

    DIPG Trial (131I-Omburtamab, Convention Enhanced Delivery)

    Not yet recruiting
    • DIPG
    • (no location specified)
    Feb 7, 2022

    Neuroblastoma Trial in United States (131I-MIBG, Dinutuximab, Vorinostat)

    Recruiting
    • Neuroblastoma
    • 131I-MIBG
    • +4 more
    • Los Angeles, California
    • +11 more
    Jan 30, 2023

    B-ALL, DLBCL, B ALL Trial in New York (131-I Apamistamab, CAR T-cell)

    Recruiting
    • B-ALL
    • +10 more
    • 131-I Apamistamab
    • CAR T-cell
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Mar 7, 2022

    Colorectal Tumors Trial in Heidelberg (Capecitabine, 131I-huA33 (131-Iodine on humanised mAb A33))

    Completed
    Has Results
    • Colorectal Neoplasms
    • Capecitabine
    • 131I-huA33 (131-Iodine on humanised monoclonal antibody A33)
    • Heidelberg, Victoria, Australia
      Ludwig Institute Oncology Unit and Tumor Targeting Program, Aust
    Jan 11, 2022

    Differentiated Thyroid Cancer, Pediatric Cancer, Cancer Trial (Larotrectinib monotherapy, 131I therapy)

    Not yet recruiting
    • Differentiated Thyroid Cancer
    • +3 more
    • Larotrectinib monotherapy
    • 131I therapy
    • (no location specified)
    Mar 13, 2023

    Peritoneal Cancer Trial in New York (131 I-8H9)

    Active, not recruiting
    • Peritoneal Cancer
    • 131 I-8H9
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Feb 7, 2022

    Waldenstrom Macroglobulinemia, Multiple Myeloma, Chronic Lymphocytic Leukemia Trial in Worldwide (Iopofosine I 131 single dose,

    Recruiting
    • Waldenstrom Macroglobulinemia
    • +8 more
    • Iopofosine I 131 single dose
    • +2 more
    • Redlands, California
    • +42 more
    Dec 30, 2022

    Glioblastoma Multiforme Trial in Australia, Austria, Netherlands (4-L-[131I]iodo-phenylalanine (131I-IPA))

    Active, not recruiting
    • Glioblastoma Multiforme
    • 4-L-[131I]iodo-phenylalanine (131I-IPA)
    • Gateshead, New South Wales, Australia
    • +4 more
    Nov 25, 2021

    Glioma, Childhood Brainstem, Neuroblastoma Trial in San Francisco, Boston (External beam radiotherapy,

    Not yet recruiting
    • Glioma, Childhood Brainstem
    • Neuroblastoma
    • External beam radiotherapy
    • 131I-Metaiodobenzylguanidine (MIBG)
    • San Francisco, California
    • +1 more
    Aug 17, 2023

    MIBG Avid Tumors Trial in Columbus (MIBG)

    Recruiting
    • MIBG Avid Tumors
    • Columbus, Ohio
      Nationwide Children's Hospital
    May 20, 2021

    Neuroblastoma, Neuroectodermal Tumors, Tumors Trial in United States (131I-MIBG, 131-MIBG + Vorinostat)

    Recruiting
    • Neuroblastoma
    • +2 more
    • San Francisco, California
    • +15 more
    Jan 7, 2022